Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study

Prophylactic antitubercular therapy (ATT) is widely prescribed in patients with Crohn's disease (CD) receiving antitumor necrosis factor (anti-TNF) treatment. However, antitubercular agents have been demonstrated to possess profibrotic effects. We aimed to evaluate whether ATT accelerated disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fen, Tang, Jian, Ye, Lingna, Tan, Jinyu, Qiu, Yun, Hu, Fan, He, Jinshen, Chen, Baili, He, Yao, Zeng, Zhirong, Mao, Ren, Cao, Qian, Gao, Xiang, Chen, Minhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236600/
https://www.ncbi.nlm.nih.gov/pubmed/35758823
http://dx.doi.org/10.14309/ctg.0000000000000493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236600/
https://www.ncbi.nlm.nih.gov/pubmed/35758823
http://dx.doi.org/10.14309/ctg.0000000000000493

Ejemplares similares